Skip to content

Nuclear Spin Modulation of Psychedelic Consciousness States: A Factorial fMRI Protocol Combining N,N-DMT with Krypton and Xenon Isotopes

Zenodo (CERN European Organization for Nuclear Research) March 4, 2026 DOI: 10.5281/zenodo.18866486 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Pre-registered factorial protocol Preregistered Peer reviewed
Interventions DMT saline placebo
Topics DMT
Keywords Krypton Isotopes of xenon Atomic physics Spin aerodynamics Noble gas Nuclear magnetic resonance
Key points The authors predict that 83Kr will amplify DMT neuroimaging signatures relative to 84Kr, that 132Xe will attenuate them, and that 129Xe will attenuate less than 132Xe due to spin-mediated neuroprotection.

Abstract

The discovery that xenon isotopes with non-zero nuclear spin are ∼30% less po-tent as anesthetics than spin-zero isotopes (Li et al., 2018) established a link betweenquantum spin and consciousness. Independently, N,N-dimethyltryptamine (DMT)induces profoundly altered conscious states characterized by global hyperconnec-tivity and apparent “channel switching” (Timmermann et al., 2023; Gallimore,2019). We propose a 2 × 2 factorial protocol that dissociates two variables—nuclearspin and anesthetic action—by crossing isotopes of two noble gases with DMTunder simultaneous EEG-fMRI. The four gas conditions are: (i) 84 Kr (spin 0, non-anesthetic; baseline control), (ii) 83 Kr (spin 9/2, non-anesthetic; pure spin ampli-fier), (iii) 132 Xe (spin 0, sub-anesthetic; pure sedation), and (iv) 129 Xe (spin 1/2,sub-anesthetic; spin + sedation). Each condition is combined with either DMT orsaline placebo, yielding eight sessions per subject. To eliminate confounding bi-ases related to differential membrane solubility between the gases, the irrefutablestrength of this protocol relies on perfectly blinded intra-element comparisons. De-signed as a pre-registered report, this study utilizes a Linear Mixed-Effects (LME)model and pre-specifies Global Functional Connectivity (GFC) as the primary end-point. We predict that 83 Kr will amplify DMT neuroimaging signatures relative to84 Kr, that 132 Xe will attenuate them, and that 129 Xe will attenuate less than 132 Xedue to spin-mediated neuroprotection.